NU SKIN ENTERPRISES, INC.NUS
時価総額
$5億
PER
美容・ウェルネス製品の大手。直販とソーシャルコマースを軸としたサブスク型販売体制を展開。2023年4月にLifeDNAを60%取得、同年6月にBeautyBioを7500万ドルで買収。米国・中国・韓国・日本を中心とする約50市場での展開。
| 2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Net income (loss) | 136 | 153 | 222 | 365 | 189 | 133 | 143 | 129 | 122 | 174 | 191 | 147 | 105 | 9 | -147 |
| Depreciation and amortization | 30 | 33 | 33 | 35 | 55 | 71 | 72 | 72 | 83 | 77 | 74 | 76 | 73 | 71 | 70 |
| Non-cash lease expense | - | - | - | - | - | - | - | - | - | - | - | 49 | 45 | 33 | 27 |
| Stock-based compensation | 11 | 15 | 21 | 33 | 18 | 7 | 9 | 19 | 27 | 10 | 24 | 23 | 12 | 16 | 15 |
| Inventory write-down | - | - | - | - | - | - | - | - | - | - | - | - | - | 88 | 48 |
| Foreign currency losses | 4 | -4 | 4 | 1 | -54 | -27 | -9 | 3 | -16 | -4 | 0 | -7 | -8 | -1 | -2 |
| (Gain) loss on disposal of assets | - | - | - | - | - | - | - | - | - | - | -3 | -13 | -0 | -1 | 0 |
| Impairment of fixed assets, goodwill and other intangibles | - | - | - | - | - | - | - | - | - | - | - | 32 | 10 | - | 181 |
| Deferred taxes | - | 0 | 5 | -42 | -10 | -17 | 18 | -39 | 15 | -2 | 12 | -6 | 52 | 18 | 55 |
| Accounts receivable, net | -7 | 6 | 8 | 34 | -31 | 2 | -3 | 0 | 10 | -3 | 11 | -20 | 11 | 23 | 8 |
| Inventories, net | -4 | -2 | 23 | 207 | 17 | -60 | -10 | -8 | 33 | -18 | 31 | 95 | -40 | 13 | -30 |
| Prepaid expenses and other | 4 | 5 | 2 | 23 | 25 | -14 | -38 | -14 | 2 | 17 | 0 | -15 | -3 | -6 | -1 |
| Other assets | -2 | 17 | 12 | 23 | 16 | 16 | 4 | 12 | -1 | 67 | 32 | 20 | -3 | -0 | 1 |
| Accounts payable | -1 | 6 | 16 | 33 | -46 | -4 | 13 | 7 | -9 | -7 | 25 | -13 | 9 | -10 | -7 |
| Accrued expenses | 14 | 2 | 62 | 389 | -309 | 16 | -34 | 22 | -7 | -87 | 87 | -105 | -121 | -38 | -28 |
| Other liabilities | 17 | 3 | 0 | 7 | -0 | -1 | 2 | 8 | -11 | 25 | 14 | 4 | -16 | -4 | -16 |
| Net cash provided by operating activities | 188 | 224 | 311 | 530 | - | - | - | 303 | 203 | 178 | 379 | 142 | 108 | 119 | 112 |
| Purchases of property and equipment | 54 | 42 | 97 | 185 | 101 | 57 | 50 | 60 | 70 | 66 | 64 | 69 | 59 | 58 | 42 |
| Proceeds on investment sales | - | 7 | 20 | 13 | 27 | 12 | 18 | 11 | 12 | 11 | 14 | 15 | 6 | 18 | 18 |
| Purchases of investments | - | 24 | 16 | 22 | 18 | 16 | 17 | 11 | 11 | 8 | 15 | 16 | 14 | 17 | 15 |
| Acquisitions (net of cash acquired) | - | 12 | 13 | - | - | - | - | - | - | 8 | 15 | 19 | - | 77 | - |
| Net cash used in investing activities | -54 | -71 | -105 | -194 | - | - | - | -92 | -109 | -71 | -79 | -89 | -67 | -135 | -38 |
| Amount of cash inflow from exercise of option under share-based payment arrangement, net of taxes paid related to the net shares settlement of stock awards. | - | - | - | - | - | - | - | - | - | -2 | 6 | 14 | 27 | 5 | -2 |
| Payment of cash dividends | 31 | 37 | 48 | 71 | 81 | 81 | 78 | 76 | 81 | 82 | 78 | 76 | 77 | 78 | 12 |
| Repurchase of shares of common stock | 59 | 67 | 201 | 141 | 46 | 164 | 247 | 72 | 70 | 1 | 144 | 80 | 70 | 13 | - |
| Finance lease principal payments | - | - | - | - | - | - | - | - | - | - | 1 | 2 | 2 | 3 | 3 |
| Contingent consideration payments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6 |
| Payment of debt issuance cost | - | - | - | - | 6 | - | 7 | - | 7 | - | - | - | 5 | - | - |
| Payments on debt | 37 | - | - | - | - | - | - | 103 | 553 | 214 | 143 | 115 | 433 | 10 | 125 |
| Proceeds from debt | 30 | - | 102 | 49 | 416 | 36 | 234 | 67 | 582 | 145 | 115 | 155 | 460 | 110 | 15 |
| Net cash (used in) provided by financing activities | -69 | -107 | -164 | -121 | - | - | - | -160 | -117 | -155 | -245 | -105 | -100 | 11 | -133 |
| Effect of exchange rate changes on cash | - | - | - | - | - | - | - | - | - | - | - | - | -16 | -4 | -10 |
| Net decrease in cash and cash equivalents | - | - | - | - | - | - | - | - | - | -51 | 67 | -63 | -75 | -9 | -69 |